Tristel plc (AIM:TSTL)

Market Cap	171.76M
Revenue (ttm)	43.56M
Net Income (ttm)	6.14M
Shares Out	47.71M
EPS (ttm)	0.13
PE Ratio	27.95
Forward PE	21.15
Dividend	0.14 (3.76%)
Ex-Dividend Date	Mar 20, 2025

Volume	48,702
Average Volume	82,853
Open	353.50
Previous Close	360.00
Day's Range	350.00 - 363.70
52-Week Range	260.00 - 490.00
Beta	0.24
RSI	37.06
Earnings Date	Oct 13, 2025

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments, Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 233
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TSTL

Financial Performance

In 2024, Tristel's revenue was 41.93 million, an increase of 16.45% compared to the previous year's 36.01 million. Earnings were 6.49 million, an increase of 45.46%.